Vanessa Marchant - Publications

Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: April 25, 2025

The Role of miR-802 in Diabetic Kidney Disease: Diagnostic and Therapeutic Insights.

Journal: International journal of molecular sciences

Published: April 24, 2025

Dasatinib and Quercetin Combination Increased Kidney Damage in Acute Folic Acid-Induced Experimental Nephropathy.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 24, 2025

CCN2 Activates Cellular Senescence Leading to Kidney Fibrosis in Folic Acid-Induced Experimental Nephropathy.

Journal: International journal of molecular sciences

Published: March 20, 2025

STING inhibition alleviates experimental peritoneal damage: potential therapeutic relevance for peritoneal dialysis.

Journal: The Journal of pathology

Published: January 31, 2025

Ccn2 Deletion Reduces Cardiac Dysfunction, Oxidative Markers, and Fibrosis Induced by Doxorubicin Administration in Mice.

Journal: International journal of molecular sciences

Published: July 18, 2024

BET Protein Inhibitor JQ1 Ameliorates Experimental Peritoneal Damage by Inhibition of Inflammation and Oxidative Stress.

Journal: Antioxidants (Basel, Switzerland)

Published: October 21, 2023

Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype.

Journal: Frontiers in cellular and infection microbiology

Published: October 06, 2023

Novel Aspects of the Immune Response Involved in the Peritoneal Damage in Chronic Kidney Disease Patients under Dialysis.

Journal: International journal of molecular sciences

Published: January 31, 2023

Type IV Collagen and SOX9 Are Molecular Targets of BET Inhibition in Experimental Glomerulosclerosis.

Journal: International journal of molecular sciences

Published: October 14, 2022

Targeting inflammation to treat diabetic kidney disease: the road to 2030.

Journal: Kidney international

Published: July 21, 2022

CCN2 Binds to Tubular Epithelial Cells in the Kidney.

Journal: Biomolecules

Published: December 30, 2021